Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson’s Dementia Complex: New Aspects for This Riddle

Table 6

A synopsis of the presence of a single or more than one NPS for each patient, during follow-up.

	3 or more NPS; num pts/48 (%)	2 or more NPS; num pts/48 (%)	1 NPS; num pts/48 (%)
NPI baseline	16 (33%)	20 (42%)	12 (25%)
NPI 6 months	12 (25%)	26 (54%)	10 (21%)
NPI 12 months	8 (17%)	28 (58%)	12 (25%)